BRS3-1-2 - Gut-Derived Inflammatory Signalling

(Endotoxin Spillover and Gut Interface Management)

1. Mission & Overview

Mission

Limit gut-derived endotoxin spillover so barrier dysfunction does not drive systemic inflammatory load.

A defined oligofructose exposure changed permeability and circulating LPS in obese mice. Human implementation and comparative route prominence remain unestablished. [14]

Intervention Dominance: Diet-Supported — No principal intervention route established

KC1 upstream supply does not itself establish intervention responsiveness. A human protocol and principal route remain unestablished. Comparative dominance and human implementation remain unestablished.

Overview

The gut barrier helps contain microbial products within the intestine. When that containment changes, endotoxin can contribute to systemic inflammatory signalling. This PM concerns the gut-derived load reaching the circulation, connecting intestinal barrier function with inflammatory regulation elsewhere. Experimental evidence identifies epithelial redox protection and a prebiotic-sensitive barrier route, while their context determines what can be inferred about dietary action. [1] [12] [14]

• Benefits: Limiting inappropriate microbial-product entry helps contain inflammatory pressure; the reviewed experiments do not establish a clinical treatment benefit. [1]
• Implementation Notes: Cysteine and glycine provide upstream glutathione resources. Oligofructose altered barrier readouts in obese mice, but a human intake protocol is not established. [11] [14]
• Biological Relevance: Gut-barrier processes connect BRS5 to this gut-derived load; PM1 concerns the downstream NF-κB response.

2. Primary Biological Effects

Gut-to-blood microbial-product handling; barrier-related systemic inflammatory signalling.

3. Intervention Levers

4. Mechanistic Basis

Summary

Systemic inflammatory tone can be driven partly by gut-derived signals. When barrier integrity weakens, endotoxin and related microbial inputs enter circulation more readily, increasing low-grade inflammatory signalling within BRS3(FM1) - Anti-Inflammatory Signalling Tone.

4.1 Scientific Findings (4)

Summary

The evidence supports gut-derived inflammatory load as a barrier-related process. Glutathione participates in oxidant-sensitive epithelial protection, but is not a universal barrier constraint. A defined prebiotic intervention changed permeability and circulating LPS in obese mice; this does not establish a generic fibre requirement or a human intake target.

5. BRS Pathways and Connections

5.1 BRS Pathways

• None listed

5.2 Cross-BRS Mechanism Relationships

Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.

• BRS5-FM1-PM1 — Gut Barrier / Tight Junction Integrity — Tight-junction integrity limits lipopolysaccharide crossing into the circulation that this page treats as the inflammatory exposure.
• BRS5(FM1) — Gut Barrier Integrity and Immune Interface — The gut–immune interface is the setting in which barrier failure lets microbial products raise systemic inflammatory signalling.
• BRS6-FM1-PM2 — Glycaemic Variability Regulation — Glycaemic variability is neighbouring metabolic context. It is not the measurement of endotoxin crossing the gut barrier.

5.3 Local BRS Mechanism Relationships

Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.

• BRS3-FM1-PM1 - NF-kB Signalling Regulation — NF-κB transcriptional control is the neighbouring response once inflammatory load is already raised. It is not this gut-entry step.

7. Phenome Connections

These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.

Focus / Attention Stability — modulatesOpen Page →→

Cognitive Clarity — modulatesOpen Page →→

Emotional Regulation — modulatesOpen Page →→

Apprehensive Worry / Perseverative Thought — modulatesOpen Page →→

Social Engagement Capacity — indirectOpen Page →→

Stage 2A/2B dietary-target assessment — 23 October 2026

ENRICHED. Host exposure and responses to gut-associated endotoxin, distinct from barrier and cytokine endpoints.

Add the qualified mixed-meal SOP and Finding for postprandial LAL/LBP readouts; no direct gut-leakage or tissue-source claim. Add provisional glycine foods only for retained upstream supply. No isolated-ingredient or brain outcome admission.

New implementation: 0 dietary-input admissions (0 completed Unset candidates), 1 practices, 0 biochemical participants, 1 unscored Findings. Existing accepted inputs, source assessments, mission, KCs, Phenome relationships and scores are retained.

Source-to-claim boundary: Assessment source. Stop after adjudicating the stated material candidate and tracing supported delivery. Keep uncertain specificity, formulation, anatomical or measurement links explicit; no negative evidence is inferred from incomplete retrieval.

8. References

• [1] Mohammad and Thiemermann (2021) — Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions
• [2] Batey et al. (2024) — Understanding Implications for Depression
• [3] Jiang et al. (2018) — Gut Microbiota Profiles in Treatment-naïve Children with Attention Deficit Hyperactivity Disorder
• [4] Prehn-Kristensen et al. (2018) — Reduced Microbiome Alpha Diversity in ADHD
• [5] Yunting Li et al. (2024) — Sodium Butyrate and Neuroinflammation
• [6] Cavaliere et al. (2022) — Butyrate and Neuroinflammation
• [7] Grüter et al. (2023) — Propionate in the Peripheral Nervous System
• [8] Hoyles et al. (2018) — Propionate and the Blood–Brain Barrier
• [9] Bravo et al. (2011) — Ingestion of Lactobacillus Strain Regulates Emotional Behavior and Central GABA Receptor Expression
• [10] Koh et al. (2016) — From Dietary Fiber to Host Physiology
• [11] Sekhar et al. (2011)
• [12] Rao et al. (2000)
• [13] van Ampting et al. (2009)
• [14] Cani et al. (2009)
• [15] Ghanim et al. (2009) — Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance.

Therapeutic Area evidence

Condition interpretations below reference canonical evidence records; study facts are not rewritten on this mechanism page.

• ADHD
  • brs3-fm1-pm2-ec000141 — Reduced microbiome alpha diversity reported in ADHD Open this evidence